超细纤维
诱导多能干细胞
祖细胞
移植
背景(考古学)
再生医学
再生(生物学)
干细胞
肺
组织工程
体内
胚胎干细胞
细胞生物学
生物医学工程
材料科学
生物
医学
外科
内科学
生物技术
古生物学
生物化学
复合材料
基因
作者
Satoshi Ikeo,Yuki Yamamoto,Kazuhiro Ikeda,Naoyuki Sone,Y. Korogi,Lucia Tomiyama,Hisako Matsumoto,Toyohiro Hirai,Masatoshi Hagiwara,Shimpei Gotoh
出处
期刊:Biomaterials
[Elsevier BV]
日期:2021-07-19
卷期号:276: 121031-121031
被引量:15
标识
DOI:10.1016/j.biomaterials.2021.121031
摘要
Lung transplantation is the only treatment available for end-stage lung diseases; however, donor shortage is a global issue. The use of human pluripotent stem cells (hPSCs) for organ regeneration is a promising approach. Nevertheless, methods for the expansion of isolated hPSC-derived lung progenitors (hLPs) for transplantation purposes have not yet been reported. Herein, we established an expansion system of hLPs based on their three-dimensional culture in core-shell hydrogel microfibers, that ensures the maintenance of their bipotency for differentiation into alveolar and airway epithelial cells including alveolar type II (AT2) cells. Further, we developed an efficient in vivo transplantation method using an endoscope-assisted transtracheal administration system; the successful engraftment and in vivo differentiation of hLPs into alveolar epithelial cells (incorporated into the alveoli) was observed. Importantly, expanded hLPs in the context of microfibers were successfully transplanted into the murine lungs, opening avenues for cell-based therapies of lung diseases. Therefore, our novel method has potential regenerative medicine applications; additionally, the high-quality hLPs and AT2 cells generated via the microfiber-based technology are valuable for drug discovery purposes.
科研通智能强力驱动
Strongly Powered by AbleSci AI